Matthew Hutson

The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.

Going from blood sample to diagnosis in the same work shift, rapid genomic sequencing proves its worth in clinical settings.

A growing wave of novel substances for performance enhancement or just getting high hits the streets weekly.

New research reveals how people feel about being judged by algorithms—and why employees should have first dibs on their data.

While AI may not end the world the way sci-fi writers imagine, it may very well pull your strings in the near future.

Deep learning uncovers the potential of existing medications to target different diseases.

Gene tests for antidepressants are going mainstream — and getting more confusing. Here’s a guide.